Assessment of Lower Urinary Tract Symptoms and Sexual Function in Women with Metabolic Syndrome

Objective To assess lower urinary tract symptoms and sexual function in premenopausal women with metabolic syndrome (MetS). Materials and Methods A total of 34 premenopausal patients over 18 years of age with MetS and who were admitted to our endocrinology clinic between September 2013 and Apri...

Full description

Bibliographic Details
Main Authors: Serkan Borazan, Gökhan Temeltaş, Oktay Üçer, Zeliha Hekimsoy, Emel Şenol
Format: Article
Language:English
Published: Galenos Yayinevi 2015-03-01
Series:Journal of Urological Surgery
Subjects:
Online Access:http://jurolsurgery.org/article_8778/Assessment-Of-Lower-Urinary-Tract-Symptoms-And-Sexual-Function-In-Women-With-Metabolic-Syndrome
_version_ 1797915201755938816
author Serkan Borazan
Gökhan Temeltaş
Oktay Üçer
Zeliha Hekimsoy
Emel Şenol
author_facet Serkan Borazan
Gökhan Temeltaş
Oktay Üçer
Zeliha Hekimsoy
Emel Şenol
author_sort Serkan Borazan
collection DOAJ
description Objective To assess lower urinary tract symptoms and sexual function in premenopausal women with metabolic syndrome (MetS). Materials and Methods A total of 34 premenopausal patients over 18 years of age with MetS and who were admitted to our endocrinology clinic between September 2013 and April 2014 were included. Control group was consisted of 30 healthy controls chosen from the staff of the hospital. The sexual function, lower urinary tract symptoms and quality of life of the participants were evaluated by using Index of Female Sexual Function (IFSF), Urogenital Distress Inventory (UDI-6), and Incontinence Impact Questionnaire (IIQ-7), respectively. The scores of the patients were statistically compared with those of controls. Results The mean ages of the patient and control groups were 40.50±5.12 years and 38.17±2.12 years, respectively (p=0.09). The mean IFSF-total and all of the IFSF sub scales (except pain) in the patient group were significantly lower than those of the control group. The mean UDI-6 score of the patients was significantly higher than the controls (p=0.001). The mean IIQ-7 scores of the patients was higher than controls, however this increase was not statistically significant (p=0.11). Conclusion These findings showed that MetS affected adversely the sexual function of premenopausal women due to the fact that IFSF scores were found to be lower in women with MetS as compared to healthy controls. Moreover, IFSF score under the threshold values in patients showed that patients with MetS had sexual function disorder. These lower urinary tract symptoms in the patients with MetS did not affect the quality of life although the severity of lower urinary tract symptoms of patients with MetS was significantly worse than that in control group.
first_indexed 2024-04-10T12:37:58Z
format Article
id doaj.art-fb52f8b50ad24451ae37f166e3a4705d
institution Directory Open Access Journal
issn 2148-9580
language English
last_indexed 2024-04-10T12:37:58Z
publishDate 2015-03-01
publisher Galenos Yayinevi
record_format Article
series Journal of Urological Surgery
spelling doaj.art-fb52f8b50ad24451ae37f166e3a4705d2023-02-15T16:14:28ZengGalenos YayineviJournal of Urological Surgery2148-95802015-03-0121131610.4274/jus.174Assessment of Lower Urinary Tract Symptoms and Sexual Function in Women with Metabolic SyndromeSerkan Borazan0Gökhan Temeltaş1Oktay Üçer2Zeliha Hekimsoy3Emel Şenol4Celal Bayar University Faculty of Medicine, Department of Urology, Manisa, TurkeyCelal Bayar University Faculty of Medicine, Department of Urology, Manisa, TurkeyCelal Bayar University Faculty of Medicine, Department of Urology, Manisa, TurkeyCelal Bayar University Faculty of Medicine, Department of Endocrinology and Metabolism, Manisa, TurkeyCelal Bayar University Faculty of Medicine, Department of Endocrinology and Metabolism, Manisa, TurkeyObjective To assess lower urinary tract symptoms and sexual function in premenopausal women with metabolic syndrome (MetS). Materials and Methods A total of 34 premenopausal patients over 18 years of age with MetS and who were admitted to our endocrinology clinic between September 2013 and April 2014 were included. Control group was consisted of 30 healthy controls chosen from the staff of the hospital. The sexual function, lower urinary tract symptoms and quality of life of the participants were evaluated by using Index of Female Sexual Function (IFSF), Urogenital Distress Inventory (UDI-6), and Incontinence Impact Questionnaire (IIQ-7), respectively. The scores of the patients were statistically compared with those of controls. Results The mean ages of the patient and control groups were 40.50±5.12 years and 38.17±2.12 years, respectively (p=0.09). The mean IFSF-total and all of the IFSF sub scales (except pain) in the patient group were significantly lower than those of the control group. The mean UDI-6 score of the patients was significantly higher than the controls (p=0.001). The mean IIQ-7 scores of the patients was higher than controls, however this increase was not statistically significant (p=0.11). Conclusion These findings showed that MetS affected adversely the sexual function of premenopausal women due to the fact that IFSF scores were found to be lower in women with MetS as compared to healthy controls. Moreover, IFSF score under the threshold values in patients showed that patients with MetS had sexual function disorder. These lower urinary tract symptoms in the patients with MetS did not affect the quality of life although the severity of lower urinary tract symptoms of patients with MetS was significantly worse than that in control group.http://jurolsurgery.org/article_8778/Assessment-Of-Lower-Urinary-Tract-Symptoms-And-Sexual-Function-In-Women-With-Metabolic-SyndromeMetabolic syndromeLUTSfemale sexual functionIFSFUDI-6
spellingShingle Serkan Borazan
Gökhan Temeltaş
Oktay Üçer
Zeliha Hekimsoy
Emel Şenol
Assessment of Lower Urinary Tract Symptoms and Sexual Function in Women with Metabolic Syndrome
Journal of Urological Surgery
Metabolic syndrome
LUTS
female sexual function
IFSF
UDI-6
title Assessment of Lower Urinary Tract Symptoms and Sexual Function in Women with Metabolic Syndrome
title_full Assessment of Lower Urinary Tract Symptoms and Sexual Function in Women with Metabolic Syndrome
title_fullStr Assessment of Lower Urinary Tract Symptoms and Sexual Function in Women with Metabolic Syndrome
title_full_unstemmed Assessment of Lower Urinary Tract Symptoms and Sexual Function in Women with Metabolic Syndrome
title_short Assessment of Lower Urinary Tract Symptoms and Sexual Function in Women with Metabolic Syndrome
title_sort assessment of lower urinary tract symptoms and sexual function in women with metabolic syndrome
topic Metabolic syndrome
LUTS
female sexual function
IFSF
UDI-6
url http://jurolsurgery.org/article_8778/Assessment-Of-Lower-Urinary-Tract-Symptoms-And-Sexual-Function-In-Women-With-Metabolic-Syndrome
work_keys_str_mv AT serkanborazan assessmentoflowerurinarytractsymptomsandsexualfunctioninwomenwithmetabolicsyndrome
AT gokhantemeltas assessmentoflowerurinarytractsymptomsandsexualfunctioninwomenwithmetabolicsyndrome
AT oktayucer assessmentoflowerurinarytractsymptomsandsexualfunctioninwomenwithmetabolicsyndrome
AT zelihahekimsoy assessmentoflowerurinarytractsymptomsandsexualfunctioninwomenwithmetabolicsyndrome
AT emelsenol assessmentoflowerurinarytractsymptomsandsexualfunctioninwomenwithmetabolicsyndrome